10-104641461-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_014978.3(SORCS3):c.134G>A(p.Arg45His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000593 in 1,466,600 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_014978.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SORCS3 | NM_014978.3 | c.134G>A | p.Arg45His | missense_variant | 1/27 | ENST00000369701.8 | NP_055793.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SORCS3 | ENST00000369701.8 | c.134G>A | p.Arg45His | missense_variant | 1/27 | 1 | NM_014978.3 | ENSP00000358715 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000329 AC: 50AN: 152004Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.0000144 AC: 1AN: 69492Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 40308
GnomAD4 exome AF: 0.0000274 AC: 36AN: 1314488Hom.: 0 Cov.: 31 AF XY: 0.0000232 AC XY: 15AN XY: 647414
GnomAD4 genome AF: 0.000335 AC: 51AN: 152112Hom.: 1 Cov.: 32 AF XY: 0.000336 AC XY: 25AN XY: 74376
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 25, 2022 | The c.134G>A (p.R45H) alteration is located in exon 1 (coding exon 1) of the SORCS3 gene. This alteration results from a G to A substitution at nucleotide position 134, causing the arginine (R) at amino acid position 45 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at